Bulletin: Black Hills Corp.'s Planned Sale Of Energy Marketing Unit Won't Affect Ratings Or Outlook Jan 12

  • ID: 2041572
  • January 2012
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Jan. 19, 2012--Standard & Poor's Ratings Services said today that Black Hills Corp.'s (BBB-/Stable/--) recently announced plan to sell its energy marketing business, Enserco Energy Inc., has no immediate impact on its ratings or outlook on Black Hills. The company expects the transaction to close in the first quarter of 2012. The completed transaction would improve Black Hills' business risk profile due to the divestiture of the higher-risk trading and marketing business. We expect that Black Hills will use some of the proceeds to pay down short-term debt and fund upcoming utility expenditures....

Companies mentioned in this report are: Black Hills Corp.
Action: Bulletin

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Black Hills Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.